Two Cases and Review of the Literature: Primary Percutaneous Angiography and Antiplatelet Management in Patients with Immune Thrombocytopenic Purpura

We report two cases of immune thrombocytopenic purpura (ITP) associated with acute coronary artery syndrome highlighting the interventions done in every case along with the medications used during intervention and as outpatient. The first case is that of a woman with ITP exacerbation while on dual antiplatelet therapy and the second case is that of a male presenting with non-ST elevation myocardial infarction (NSTEMI) while in a thrombocytopenic crisis. In both cases antiplatelet therapy was held and thrombopoietic therapy was initiated before resuming full anticoagulation and coronary intervention. Given the paucity of data on ITP and antiplatelets treatment in the setting of acute coronary syndrome, no strict recommendations can be proposed, but antiplatelets appear to be safe acutely and in the long term in this category of patients as long as few measures are undertaken to minimize the risks of bleeding and thrombosis.

[1]  L. Cornillet,et al.  Myocardial infarction after rituximab infusion , 2013, Neuromuscular Disorders.

[2]  W. van Gaal,et al.  A case of acute stent thrombosis during treatment with the thrombopoietin receptor agonist peptide--romiplostim. , 2012, Heart, lung & circulation.

[3]  N. Ermis,et al.  Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura. , 2012, Texas Heart Institute journal.

[4]  Y. Kita,et al.  Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies , 2012, Journal of Thrombosis and Thrombolysis.

[5]  A. Branzi,et al.   2011 Published by European Association for Cardio-thoracic Surgery Idiopathic Thrombocytopenic Purpura and Coronary Artery Disease: Comparison between Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention , 2022 .

[6]  M. Ergelen,et al.  [Primary coronary intervention for acute ST-elevation myocardial infarction in a patient with immune thrombocytopenic purpura]. , 2011, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[7]  J. Fox,et al.  Acute ST Elevation Myocardial Infarction in Patients With Immune Thrombocytopenia Purpura: A Case Report , 2011, Cardiology research.

[8]  A. Neskovic,et al.  Concomitant administration of simvastatin and danazol associated with fatal rhabdomyolysis. , 2010, Clinical therapeutics.

[9]  K. Keskin,et al.  Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in a Young Female with Idiopathic Thrombocytopenic Purpura: A Case Report and Review , 2010, Case reports in medicine.

[10]  A. Neskovic,et al.  Primary PCI for Acute Myocardial Infarction in a Patient with Idiopathic Thrombocytopenic Purpura , 2010, Herz.

[11]  C. Kaymaz,et al.  [Antiplatelet treatment after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura]. , 2009, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[12]  G. Biondi-Zoccai,et al.  Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo? , 2008, International journal of cardiology.

[13]  M. C. Gracia,et al.  Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura. , 2008, International journal of cardiology.

[14]  K. Seung,et al.  Intracoronary Stent Deployment without Antiplatelet Agents in a Patient with Idiopathic Thrombocytopenic Purpura , 2007 .

[15]  I. Marie,et al.  Intravenous immunoglobulin‐associated arterial and venous thrombosis; report of a series and review of the literature , 2006, The British journal of dermatology.

[16]  H. Leu,et al.  Coronary revascularization in a patient with immune thrombocytopenic purpura. , 2006, Journal of the Chinese Medical Association : JCMA.

[17]  W. Chun,et al.  Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction with Idiopathic Thrombocytopenic Purpura: A Case Report , 2006, Journal of Korean medical science.

[18]  J. L. Quiñones,et al.  Angioplastia transluminal coronariana em portador de púrpura trombocitopênica idiopática , 2005 .

[19]  M. Jaloudi,et al.  Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature , 2005, Annals of Hematology.

[20]  D. Salvadori,et al.  [Percutaneous transluminal coronary angioplasty in a patient with idiopathic thrombocytopenic purpura]. , 2005, Arquivos brasileiros de cardiologia.

[21]  M. Jaloudi,et al.  Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature , 2004, Annals of Hematology.

[22]  J. Goicolea,et al.  [Severe thrombocytopenia refractory to platelet transfusions, secondary to abciximab readministration, in a patient previously diagnosed with idiopathic thrombocytopenic purpura. A possible etiopathogenic link]. , 2004, Revista espanola de cardiologia.

[23]  E. Ohman,et al.  Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  N. Ochi,et al.  [A case of intracoronary stent implanted for acute myocardial infarction in an elderly patient with idiopathic thrombocytopenic purpura]. , 2002, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[25]  O. Segal,et al.  Percutaneous coronary intervention with adjunctive abciximab and clopidogrel in a patient with chronic idiopathic thrombocytopaenic purpura. , 2001, International journal of cardiovascular interventions.

[26]  D. Churchill,et al.  Transradial coronary stent placement in a patient with severe idiopathic autoimmune thrombocytopenic purpura. , 2000, The Journal of invasive cardiology.

[27]  Y. Tofuku,et al.  [An elderly case of idiopathic thrombocytopenic purpura associated with acute myocardial infarction]. , 1999, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[28]  Mamoru Takahashi,et al.  Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. , 1999, Japanese circulation journal.

[29]  J. Mcgraw,et al.  Textbook of Cardiovascular Medicine , 1998 .